We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Regulatory change allows reliance on animal-free alternatives before human trials, indicating a shift in drug approval processes.
Agency can rely on animal-free alternatives before human trials.
No takes yet. Share an insight, caveat, or question.
Meredith Wadman (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: